Efficacy, tolerability and remission: a 15 year switching study of oral antipsychotics from typical to atypical and back

被引：1
|
作者：
Franza, F. [1 ]
Dinelli, G. [2 ]
Fiorentino, N. [1 ]
di Celso, R. Mazziotti [1 ]
Dinelli, E. [2 ]
Soddu, A. [1 ]
Fasano, V. [1 ]
Battista, A. [1 ]
机构：
[1] Casa Cura Villa Pini, Dept Psychiat, Avellino, Italy
[2] Casa Cura Pk Villa Napoleon, Dept Psychiat, Preganziol, TV, Italy
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2012年 / 22卷
关键词：
D O I：
10.1016/S0924-977X(12)70485-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S317 / S317
页数：1
相关论文
共 50 条
  • [41] Tolerability of monthly oral ibandronate in postmenopausal osteoporosis: 1-year results from the MOBILE study
    Recker, RR
    Silverman, SL
    Kendler, DL
    Dumont, E
    Hughes, BBC
    Reginster, JY
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S293 - S294
  • [42] Long-term efficacy and tolerability of lanthanum carbonate:: Results from a 3-year study
    Hutchison, AJ
    Maes, B
    Vanwalleghem, J
    Asmus, G
    Mohamed, E
    Schmieder, R
    Backs, W
    Jamar, R
    Vosskühler, A
    NEPHRON CLINICAL PRACTICE, 2006, 102 (02): : 61 - 71
  • [43] Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: A two-year, randomized, placebo-controlled study
    Hsieh, MH
    Chan, P
    Sue, YM
    Liu, JC
    Liang, TH
    Huang, TY
    Tomlinson, B
    Sum, MS
    Kao, PF
    Chen, YJ
    CLINICAL THERAPEUTICS, 2003, 25 (11) : 2797 - 2808
  • [44] Bouncing back: remission from depression in a 12-year panel study of a representative Canadian community sample
    Esme Fuller-Thomson
    Marla Battiston
    Tahany M. Gadalla
    Sarah Brennenstuhl
    Social Psychiatry and Psychiatric Epidemiology, 2014, 49 : 903 - 910
  • [45] Bouncing back: remission from depression in a 12-year panel study of a representative Canadian community sample
    Fuller-Thomson, Esme
    Battiston, Marla
    Gadalla, Tahany M.
    Brennenstuhl, Sarah
    SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2014, 49 (06) : 903 - 910
  • [46] Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: efficacy, quality of life and functional outcome
    Lloyd, Keith
    Latif, Muhammud A.
    Simpson, Steve
    Shrestha, Keshar L.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2010, 25 (03) : 243 - 252
  • [47] Safety, Tolerability and Pharmacokinetics Study in Patients with Pulmonary Arterial Hypertension (PAH) Temporarily Switching from Oral to IV Selexipag
    Klose, H.
    Chin, K.
    Ewert, R.
    Gall, H.
    Parambil, J.
    Poch, D.
    Seyfarth, H.
    Axelsen, L.
    Schmitz, S. Hsu
    Stein, C.
    Preston, I.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S490 - S490
  • [48] Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study (vol 65, pg 654, 2006)
    Reginster, J-Y
    Adami, S.
    Lakatos, P.
    Greenwald, M.
    Stepan, J. J.
    Silverman, S. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (02) : 280 - 280
  • [49] Efficacy and tolerability of switching from olanzapine, risperidone and haloperidol to ziprasidone in patients with schizophrenia: An international multi-center study
    Alptekin, K.
    Karayal, O. N.
    Brook, S.
    Akkaya, C.
    Tzebelikos, E.
    EUROPEAN PSYCHIATRY, 2008, 23 : S122 - S123
  • [50] Long-term safety, efficacy and tolerability of lanthanum carbonate: Results from a 3.5-year study
    Hutchison, A
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V5 - V5
12345